Sponsor of the Day:
Jerkmate
https://www.medrxiv.org/content/10.1101/2020.04.16.20067835v1
Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs |...
Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing COVID-19 pandemic. The current gold standard for COVID-19 diagnosis...
sars cov 2covid 19 patientssalivasensitivedetection
https://www.engadget.com/mit-csail-coronavirus-patient-monitoring-device-190037775.html
MIT uses wireless signals and AI to monitor COVID-19 patients at home
Apr 14, 2020 - A team from MIT's CSAIL developed a wireless device that uses AI to monitor COVID-19 patients in their homes.
covid 19 patientswireless signalsmitusesai
https://www.cureus.com/articles/179159-doxycycline-vs-hydroxychloroquine--azithromycin-in-the-management-of-covid-19-patients-an-open-label-randomized-clinical-trial-in-sub-saharan-africa-doxycov
Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An...
Objective We aimed to compare the safety and efficacy of a doxycycline-based regimen against Cameroon National Standard Guidelines (hydroxychloroquine plus...
covid 19 patientsdoxycyclinevshydroxychloroquineazithromycin
https://www.panafrican-med-journal.com/content/series/37/1/9/full/
Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients...
INTRODUCTION: COVID-19 is a global pandemic seen in modern times. The clinical characteristics, treatment regimen and duration of hospitalization of COVID-19...
covid 19 patientsclinical characteristicstreatmentregimenduration
https://www.medrxiv.org/content/10.1101/2020.05.12.20099028v1
Outcomes of Hydroxychloroquine Treatment Among Hospitalized COVID-19 Patients in the United States-...
On March 28, 2020, in response to the rapidly accelerating COVID-19 pandemic, U.S FDA issued emergency use authorization for hydroxychloroquine (HCQ) in...
among hospitalized covid19 patientsunited statesoutcomeshydroxychloroquine
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0244272
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital...
Objectives To describe the clinical characteristics of patients infected with SARS-CoV-2 at Clinique Ngaliema, a public hospital, in Kinshasa, in the...
covid 19 patientsclinical characteristicspublic hospitalhospitalizedclinique
https://link.springer.com/article/10.1007/s11739-021-02742-8?error=cookies_not_supported&code=f4e17665-438e-412e-9554-7ccd1804d886
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards...
Apr 24, 2021 - During the COVID-19 2020 outbreak, a large body of data has been provided on general management and outcomes of hospitalized COVID-19 patients. Yet, relati
covid 19 patientsclinical factorsinternal medicineassociateddeath
https://www.jstage.jst.go.jp/article/tjem/252/1/252_73/_article
Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
mortality risk factorsamong hospitalized covid19 patientsreferral centermajor
https://www.medrxiv.org/content/10.1101/2021.03.08.21252883v1
Outcome of Different Therapeutic Interventions in Mild COVID-19 Patients in a Single OPD Clinic of...
Introduction With over 87,273,380 cases being reported and 1,899,440 deaths worldwide as of 9th January 2021, Coronavirus disease 2019 (COVID-19) has become...
mild covid 19different therapeuticoutcomeinterventionspatients
https://www.factcheck.org/2022/09/scicheck-clinical-trials-show-ivermectin-does-not-benefit-covid-19-patients-contrary-to-social-media-claims/
Clinical Trials Show Ivermectin Does Not Benefit COVID-19 Patients, Contrary to Social Media Claims...
Jun 3, 2024 - Randomized clinical trials have repeatedly found that ivermectin does not benefit COVID-19 patients. The National Institutes of Health recommends against its...
covid 19 patientsclinical trialssocial mediashowivermectin
https://www.medrxiv.org/content/10.1101/2021.07.06.21259924v1
Effectiveness of Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 Patients...
Ivermectin is a safe, inexpensive and effective early COVID-19 treatment validated in 20+ RCTs. Having developed combination therapies for Helicobacter pylori...
covid 19 patientseffectivenessivermectinbasedmultidrug
https://link.springer.com/article/10.1007/s11739-020-02505-x?error=cookies_not_supported&code=ff806a37-8ea3-40fa-8e24-87f6235418dc
The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients |...
Sep 30, 2020 - This study investigates the association between the treatment with hydroxychloroquine and mortality in patients admitted with COVID-19. Routinely recorded,
covid 19 patientshospital mortalityassociationtreatmenthydroxychloroquine
https://www.medrxiv.org/content/10.1101/2020.09.09.20184143v1
The Effect of Early Hydroxychloroquine-based Therapy in COVID-19 Patients in Ambulatory Care...
BACKGROUND Currently, there is no proven effective therapy nor vaccine for the treatment of SARS-CoV-2. Evidence regarding the potential benefit of early...
covid 19 patientsbased therapyambulatory careeffectearly
https://link.springer.com/article/10.1007/s11427-020-1782-1?error=cookies_not_supported&code=d3bff5b3-ec2f-4006-bbef-9c740dac760c
Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting...
covid 19 patientsbeneficial effectsexertedhydroxychloroquinetreating
https://www.medrxiv.org/content/10.1101/2021.03.08.21252883v2
Outcome of Different Therapeutic Interventions in Mild COVID-19 Patients in a Single OPD Clinic of...
Introduction With over 87,273,380 cases being reported and 1,899,440 deaths worldwide as of 9th January 2021, Coronavirus disease 2019 (COVID-19) has become...
mild covid 19different therapeuticoutcomeinterventionspatients
https://www.center4research.org/nchr-long-covid-teleconferences-national-conference-project/
Improving Outcomes for Long COVID-19 Patients - National Center for Health Research
Feb 7, 2023 - The project “Engaging Stakeholders in Patient-Centered Outcomes Research and Clinical Effectiveness Research to Improve Outcomes for Post-Acute COVID-19...
long covid 19national center healthimproving outcomespatientsresearch
https://c19early.org/efimenko.html
Efimenko: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients:...
covid 19 patientstreatmentivermectinassociateddecreased
https://www.cureus.com/articles/122896-predictive-factors-of-death-and-the-clinical-profile-of-hospitalized-covid-19-patients-in-morocco-a-one-year-mixed-cohort-study
Predictive Factors of Death and the Clinical Profile of Hospitalized Covid-19 Patients in Morocco:...
Background Since the onset of the Covid-19 pandemic, several studies have been conducted around the world in an attempt to understand this heterogeneous and...
hospitalized covid 19clinical profilepredictivefactorsdeath
https://ufhealth.org/news/2021/two-drug-combo-shows-dramatic-results-covid-19-patients-uf-health-researchers-find
Two-drug combo shows dramatic results for COVID-19 patients, UF Health researchers find - UF Health
Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study…
covid 19 patientstwo drugshows dramaticuf healthresearchers find
https://www.cbsnews.com/baltimore/news/8-year-old-columbia-girl-uses-birthday-to-raise-money-for-covid-19-patients/
8-Year-Old Columbia Girl Uses Birthday To Raise Money For COVID-19 Patients - CBS Baltimore
Aug 29, 2020 - Ada Cottrell celebrated her 8th birthday by raising money for people during the coronavirus pandemic.
8 year oldcovid 19 patientsgirl usesraise moneycbs baltimore
https://www.cureus.com/articles/263779-anticoagulant-use-in-covid-19-patients-a-longitudinal-study-from-zanjan-iran
Anticoagulant Use in COVID-19 Patients: A Longitudinal Study From Zanjan, Iran | Cureus
Background The mortality and morbidity of thrombotic events in patients with coronavirus disease 2019 (COVID-19) are increasing worldwide. The clinical impact...
covid 19 patientslongitudinal studyanticoagulantuseiran
https://www.medrxiv.org/content/10.1101/2021.03.04.21252084v1
Factors associated with increased mortality in critically ill COVID-19 patients in a Mexican public...
BACKGROUND The lethality rate of COVID-19 in Mexico is one of the highest worldwide, but in-hospital factors associated with this increased rate have yet to be...
covid 19 patientsfactors associatedcritically illincreasedmortality
https://www.pjms.org.pk/index.php/pjms/article/view/8757
Effectiveness of early pharmaceutical interventions in symptomatic COVID-19 patients: A randomized...
covid 19 patientseffectivenessearlypharmaceuticalinterventions
https://link.springer.com/article/10.1007/s11739-021-02742-8?error=cookies_not_supported&code=437d4d58-30a1-4150-a19e-a235e1ed7711
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards...
Apr 24, 2021 - During the COVID-19 2020 outbreak, a large body of data has been provided on general management and outcomes of hospitalized COVID-19 patients. Yet, relati
covid 19 patientsclinical factorsinternal medicineassociateddeath
https://www.jstage.jst.go.jp/article/tjem/252/1/252_73/_article/-char/ja/
Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran
mortality risk factorsamong hospitalized covid19 patientsreferral centermajor
https://www.factcheck.org/2021/08/scicheck-hospitals-overwhelmed-by-another-surge-of-covid-19-patients-financial-strain/
Hospitals Overwhelmed by Another Surge of COVID-19 Patients, Financial Strain - FactCheck.org
Aug 24, 2021 - The seven-day average of COVID-19 hospitalizations in the U.S. has increased by 322% in two months, straining the ability of medical staff in some states to...
covid 19 patientsfinancial strainhospitalsoverwhelmedanother
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242184
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients | PLOS One
Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin...
severe covid 19plos onelackefficacystandard
https://www.news-medical.net/news/20260424/COVID-19-patients-with-STEMI-show-higher-one-year-mortality-rates.aspx
COVID-19 patients with STEMI show higher one-year mortality rates
Findings from the North American COVID-19 Myocardial Infarction (NACMI) registry demonstrate significantly higher one-year mortality rates in patients with...
covid 19 patientsone year mortalityshow higherstemirates
https://www.medrxiv.org/content/10.1101/2021.03.04.21252084v1.supplementary-material
Factors associated with increased mortality in critically ill COVID-19 patients in a Mexican public...
BACKGROUND The lethality rate of COVID-19 in Mexico is one of the highest worldwide, but in-hospital factors associated with this increased rate have yet to be...
covid 19 patientsfactors associatedcritically illincreasedmortality
https://c19early.org/charif.html
Charif: Predictive Factors of Death and the Clinical Profile of Hospitalized Covid-19 Patients in...
Charif, 615 patient HCQ late treatment study: 27% lower mortality (p=0.0005). Retrospective 615 hospitalized COVID-19 patients in Morocco, showing lower.. -...
hospitalized covid 19clinical profilecharifpredictivefactors
https://www.belgiqueenbonnesante.be/fr/donnees-phares-dans-les-soins-de-sante/covid-19-fr/activite-de-soins/chiffres-epidemiologiques/covid-19-patients-dans-les-hopitaux-generaux
COVID-19 patients dans les hôpitaux généraux - Vers une Belgique en bonne santé
Jan 30, 2023 - Vers une Belgique en bonne santé: indicateurs de santé et de soins
covid 19 patientsvers une belgiquedans lesbonne
https://www.medrxiv.org/content/10.1101/2023.07.13.23292643v1
Clinical manifestations and mortality among hospitalized COVID-19 patients in Tanzania, 2021-2022 |...
among hospitalized covidclinical manifestations19 patients2021 2022mortality
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238281
Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia,...
This is a population-based prospective cohort study on archive data describing the age- and sex-specific prevalence of COVID-19 and its prognostic factors. All...
covid 19 patientsreggio emiliacharacteristicsoutcomescohort
https://www.medrxiv.org/content/10.1101/2020.12.11.20247437v1
Clinical and Demographic Characteristics of COVID-19 Patients Admitted in a Tertiary Care Hospital...
To present clinical and demographic characteristics of COVID-19 patients admitted to Hospital Metropolitano de Santiago in Dominican Republic, we analyzed...
covid 19 patientstertiary care hospitaldemographic characteristicsclinicaladmitted
https://www.nature.com/articles/s41419-020-2721-8?error=cookies_not_supported&code=516037a2-dc69-479f-add6-e2b062193c42
Is hydroxychloroquine beneficial for COVID-19 patients? | Cell Death & Disease
Jul 8, 2020 - The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019....
covid 19 patientscell deathhydroxychloroquinebeneficialdisease
https://c19early.org/tehrani.html
Tehrani: Risk factors for mortality in adult COVID-19 patients: frailty predicts fatal outcome in...
Tehrani, 255 patient HCQ late treatment study: 13% lower mortality (p=0.63). Retrospective 255 hospitalized patients, 65 treated with HCQ, showing unadjusted.....
covid 19 patientsrisk factorstehranimortalityadult
https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0244272
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital...
Objectives To describe the clinical characteristics of patients infected with SARS-CoV-2 at Clinique Ngaliema, a public hospital, in Kinshasa, in the...
covid 19 patientsclinical characteristicspublic hospitalhospitalizedclinique
https://link.springer.com/article/10.1007/s11427-020-1782-1?error=cookies_not_supported&code=5e505e8d-ce46-4ceb-b130-2915e5b8cb8f
Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting...
covid 19 patientsbeneficial effectsexertedhydroxychloroquinetreating
https://www.medrxiv.org/content/10.1101/2020.08.05.20151027v1
Time to negative PCR from symptom onset in COVID-19 patients on Hydroxychloroquine and Azithromycin...
Background The role of hydroxychloroquine (HCQ) and azithromycin in the treatment of COVID-19 and its effect on SARS-CoV-2 viral clearance is not known....
covid 19 patientstimenegativepcrsymptom
https://www.ijsciences.com/pub/article/2378
Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
sars cov 2covid 19 patientseffectivenessivermectin
https://advances.massgeneral.org/cardiovascular/article.aspx?id=1179
ECMO as a Rescue Therapy for COVID-19 Patients - Mass General Advances in Motion
Massachusetts General Hospital physicians have successfully used extracorporeal membrane oxygenation (ECMO) therapy as a bridge to recovery for critically ill...
covid 19 patientsmass general advancesecmorescuetherapy
https://link.springer.com/article/10.1007/s10067-020-05334-7?error=cookies_not_supported&code=9df32bc0-1394-48a5-a1e6-d21c94fdaad9
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series |...
Aug 27, 2020 - Covid-19 infection poses a serious challenge for immune-compromised patients with inflammatory autoimmune systemic diseases. We investigated the clinical-e
covid 19systemic diseaseslarge italianrheumaticautoimmune
https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0264789
Mortality and associated risk factors in patients hospitalized due to COVID-19 in a Peruvian...
associated riskpatients hospitalizedcovid 19mortalityfactors
https://www.abcimaging.org/article/cardiovascular-complications-in-patients-with-covid-19-and-their-relationship-with-mortality-an-echocardiographic-perspective/
Cardiovascular Complications in Patients with COVID-19 and Their Relationship with Mortality: An...
Apr 1, 2026 - Abstract Background: Echocardiography plays a fundamental role in the diagnosis of cardiovascular diseases related to SARS-CoV-2 infection. Despite prior
covid 19cardiovascularcomplicationspatientsrelationship
https://www.mdanderson.org/cancerwise/leukemia-oncologist-doctor-reflections-on-caring-for-cancer-patients-during-the-coronavirus-covid-19-pandemic.h00-159381156.html
Caring for leukemia patients during COVID-19: an oncologist’s reflections | UT MD Anderson
Apr 21, 2020 - What is it like to round on MD Anderson’s inpatient leukemia unit during the coronavirus (COVID-19) pandemic? Naveen Pemmaraju, M.D., shares his observations...
ut md andersoncovid 19caringleukemiapatients
https://link.springer.com/article/10.1007/s00134-021-06448-5?error=cookies_not_supported&code=4ea86434-5025-4dec-aa6e-388c3b80f55f
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP...
Jul 12, 2021 - To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19). Critically ill adu
critically ill patientslopinavir ritonavircovid 19hydroxychloroquineremap
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0264789
Mortality and associated risk factors in patients hospitalized due to COVID-19 in a Peruvian...
associated riskpatients hospitalizedcovid 19mortalityfactors
https://acutecaretesting.org/en/journal-scans/asymptomatic-severe-hypoxemia-reduced-po2
Asymptomatic severe hypoxemia is an important feature of COVID-19 for some patients; mechanisms...
Asymptomatic severe hypoxemia (reduced pO2(a)) is an important feature of COVID-19 for some patients; mechanisms discussed and prognosis examined
important featurecovid 19asymptomaticseverepatients
https://c19early.org/roig.html
Roig: Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients [HCQ]
Roig, 79 patient HCQ late treatment study: 16% lower mortality (p=0.76). Retrospective 79 hospitalized nonagenarian patients showing unadjusted HCQ mortality.....
covid 19roigclinicalpharmacologicaldata
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252388
Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19...
Background Hydroxychloroquine combined with azithromycin (HCQ/AZI) has initially been used against coronavirus disease-2019 (COVID-19). In this retrospective...
efficacy hydroxychloroquinepatients hospitalizedcovid 19lackazithromycin
https://www.nationalacademies.org/news/strategies-to-allocate-scarce-covid-19-monoclonal-antibody-treatments-to-eligible-patients-examined-in-new-rapid-response-to-government
Strategies to Allocate Scarce COVID-19 Monoclonal Antibody Treatments to Eligible Patients Examined...
Despite a scarce supply, a substantial amount of COVID-19 monoclonal antibody (mAb) treatment courses remain unused, says a new rapid expert consultation from...
covid 19monoclonal antibodystrategiesallocatescarce
https://immunopathol.com/Article/ipp-40568
Clinical signs, symptoms, and severity of COVID-19 in patients with rheumatic diseases during the...
Introduction: Recent studies have shown that patients with rheumatic diseases are more likely to experience severe cases of COVID-19. Additionally, certain...
clinical signscovid 19rheumatic diseasessymptomsseverity
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0266922
Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients | PLOS...
Background Maintenance drugs are used to treat chronic conditions. Several classes of maintenance drugs have attracted attention because of their potential to...
covid 19elderly patientseffectcommonmaintenance